On 16 February 2022, the Joint Committee on Vaccination and Immunisation (JCVI) advised a non-urgent offer of the Pfizer vaccine should be made to children aged five to 11 years old who are not in a clinical risk group. The JCVI considers this advice as a one-off response to pandemic rather than part of the routine vaccination schedule. NHS.UK includes the offer of COVID-19 vaccination for this age group on its vaccination schedule information to raise awareness with the public.<\/p>
Vaccine-induced protection against severe disease, hospitalisation and death is expected to be maintained for a longer period than protection against mild disease in children, as evidenced in the United Kingdom data for adults. Most children aged five to 11 years old who are not in a COVID-19 clinical risk group are at extremely low risk of developing severe disease with the majority experiencing asymptomatic or mild disease following infection.<\/p>
The JCVI\u2019s statement concludes that the potential health benefits of vaccination are greater than the potential health risks. Vaccination of children aged five to 11 years old who are not in a clinical risk group is expected to reduce the small number of hospitalisations and paediatric multisystem inflammatory syndrome temporally associated with COVID-19 cases. The extent of these benefits is dependent on the timing and severity of any future wave of infection.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4447", "label" : {"_value" : "Biography information for Maggie Throup"} } , "answeringMemberConstituency" : {"_value" : "Erewash"} , "answeringMemberPrinted" : {"_value" : "Maggie Throup"} , "dateOfAnswer" : {"_value" : "2022-06-21", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-06-21T11:25:31.493Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-06-13", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the evidential basis is (a) for the inclusion of covid-19 vaccinations for children in the recommended list of NHS vaccinations, (b) that demonstrates the roll out of covid-19 vaccination for children provides long-term protection against disease, (c) that demonstrates covid-19 infection presents a substantial risk to children and (d) that risks to children associated with covid-19 vaccination are outweighed by benefits of vaccination.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4865", "label" : {"_value" : "Biography information for Miriam Cates"} } , "tablingMemberConstituency" : {"_value" : "Penistone and Stocksbridge"} , "tablingMemberPrinted" : [{"_value" : "Miriam Cates"} ], "uin" : "17162"} , {"_about" : "http://data.parliament.uk/resources/1277098", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1277098/answer", "answerText" : {"_value" : "
The Government recognises that a global pandemic requires global solutions. It is essential that the Department is regularly in discussions with other countries, including Israel, on a wide range of COVID-19 issues to share learnings and collaborate internationally on the vaccination programme. Feedback from these discussions, where relevant, is used to improve the United Kingdom vaccination programme.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4113", "label" : {"_value" : "Biography information for Nadhim Zahawi"} } , "answeringMemberConstituency" : {"_value" : "Stratford-on-Avon"} , "answeringMemberPrinted" : {"_value" : "Nadhim Zahawi"} , "dateOfAnswer" : {"_value" : "2021-03-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-03-22T17:09:35.987Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2021-01-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what coordination is taking place between the UK and Israel on covid-19 vaccine deployment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4865", "label" : {"_value" : "Biography information for Miriam Cates"} } , "tablingMemberConstituency" : {"_value" : "Penistone and Stocksbridge"} , "tablingMemberPrinted" : [{"_value" : "Miriam Cates"} ], "uin" : "138541"} , {"_about" : "http://data.parliament.uk/resources/1270756", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1270756/answer", "answerText" : {"_value" : "
Funded by the Department, the National Institute for Health Research (NIHR) is the nation's largest funder of health and care research. The NIHR has led urgent public health research on COVID-19, targeted at both domestic and global research and development solutions. Outside the United Kingdom, we are funding global health research to tackle COVID-19 in low- and middle-income countries, in partnership with UK Research and Innovation, using Official Development Assistance (ODA) to fund high quality applied health research and training. Countries eligible to receive ODA are as defined by the Organisation for Economic Co-operation and Development\u2019s Development Assistance Committee list of ODA recipients. Israel is not eligible to receive ODA and as such has not been involved in the NIHR\u2019s global health research in this area.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4362", "label" : {"_value" : "Biography information for Edward Argar"} } , "answeringMemberConstituency" : {"_value" : "Charnwood"} , "answeringMemberPrinted" : {"_value" : "Edward Argar"} , "dateOfAnswer" : {"_value" : "2020-12-22", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-12-22T11:03:19.38Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-12-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Israel"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what collaborative scientific research partnerships are ongoing between the UK and Israel to combat covid-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4865", "label" : {"_value" : "Biography information for Miriam Cates"} } , "tablingMemberConstituency" : {"_value" : "Penistone and Stocksbridge"} , "tablingMemberPrinted" : [{"_value" : "Miriam Cates"} ], "uin" : "129166"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 3, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }